Advanced search
Publication Cover
Autoimmunity Volume 50, 2017 - Issue 2
Submit an article Journal homepage
217
Views
11
CrossRef citations to date
0
Altmetric
Short Communication

Type-III interferons and rheumatoid arthritis: Correlation between interferon lambda 1 (interleukin 29) and antimutated citrullinated vimentin antibody levels

Diana Castillo-MartínezDepartment of Dermatology, Hospital General de Zona 32, Instituto Mexicano del Seguro Social, Tlalpan, Mexico City, Mexico,
,
Maribel JuarezDepartment of Rheumatology,
,
Mariana PatlánDepartment of Immunology,
,
Araceli PáezDepartment of Physiology, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, Mexico City, Mexico,
,
Felipe MassóDepartment of Physiology, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, Mexico City, Mexico,
&
Luis M. Amezcua-GuerraDepartment of Immunology, ;Department of Health Care, Universidad Autónoma Metropolitana - Xochimilco, Coyoacán, Mexico City, Mexico, and ;School of Medicine, LaSalle University, Cuauhtémoc, Mexico City, MexicoCorrespondence[email protected]
Pages 82-85 | Received 06 Sep 2016, Accepted 22 Jan 2017, Published online: 14 Feb 2017

References

  • Choi, S. I., and E. Brahn. 2010. Rheumatoid arthritis therapy: advances from bench to bedside. Autoimmunity. 43: 478–492.
  • Rodríguez-Carrio, J., B. de Paz, P. López, et al. 2014. IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients. PLoS One 9: e86069
  • Sheppard, P., W. Kindsvogel, W. Xu, et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4: 63–68.
  • Kotenko, S. V, G. Gallagher, V. V. Baurin, et al. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69–77.
  • Xu, L., X. Feng, W. Tan, et al. 2013. IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients. Arthritis. Res. Ther. 15: R170.
  • de Groen, R. A., A. Boltjes, J. Hou, et al. 2015. IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells. Eur. J. Immunol. 45: 250–259.
  • Megjugorac, N. J., G. E. Gallagher, and G. Gallagher. 2009. Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29). J. Leukoc. Biol. 86: 1359–1363.
  • Wu, Q., Q. Yang, H. Sun, et al. 2013. Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients. Autoimmunity. 46: 40–43.
  • Aletaha, D., T. Neogi, A. J. Silman, et al. 2010. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 62: 2569–2581.
  • Amezcua-Guerra, L. M., D. Ferrusquía-Toriz, D. et al. 2015. Limited effectiveness for the therapeutic blockade of interferon α in systemic lupus erythematosus: a possible role for type III interferons. Rheumatology (Oxford). 54: 203–205.
  • Dantas, A. T., S. M. C. Gonçalves, M. C. Pereira, et al. 2015. Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29). Autoimmunity. 48: 429–433.
  • Degboé, Y., A. Constantin, D. Nigon, et al. 2015. Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort. RMD Open. 1: e000180.
  • Reyes-Castillo, Z., C. A. Palafox-Sánchez, I. Parra-Rojas, et al. 2015. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin. Exp. Immunol. 182: 119–131.
  • Benham, H., H. J. Nel, S. C. Law, et al 2015. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl. Med. 7:290ra87.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.